biotech

Biotech’s ‘nauseating roller coaster’ repels investors
BioSpace
Wed, 04/23/25 - 11:12 am
biotech
tariffs
investors
How affirmative action ruling, federal funding cuts impact pharma and biotech
Medical Marketing and Media
Mon, 04/21/25 - 06:00 pm
pharma industry
biotech
affirmative action
‘Chaos’ in the biotech market has dampened hopes of a rebound. What does that mean for dealmaking and IPOs?
Pharma Voice
Tue, 04/15/25 - 09:54 am
biotech
biotech stocks
tariffs
M&A
IPOs
Market volatility compounds ‘already challenging’ year for biotech IPOs
Fierce Biotech
Fri, 04/11/25 - 11:21 am
biotech
IPOs
stock market
Donald Trump
tariffs
Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts
BioPharma Dive
Thu, 04/10/25 - 11:48 am
biotech
venture capital
FDA
layoffs
US risks losing biotech edge to China, report warns
BioPharma Dive
Tue, 04/8/25 - 10:56 pm
biotech
funding
China
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs
BioPharma Dive
Thu, 04/3/25 - 11:18 am
biotech
funding
IPOs
venture capital
Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis
Fierce Biotech
Tue, 04/1/25 - 11:46 am
layoffs
biotech
cell therapy
gene therapy
New Chan Zuckerberg biohub to focus on cells' inner workings
Axios
Fri, 03/28/25 - 11:11 am
biotech
imaging
Mark Zuckerberg
Priscilla Chan
California
Funding drought: how can biotech and biopharma keep trials running?
Clinical Trials Arena
Thu, 03/20/25 - 11:12 am
funding
biotech
clinical trials
The key factors shaping China’s biopharma boom
Pharma Voice
Thu, 03/20/25 - 09:57 am
China
biotech
tariffs
regulatory
CAR-T
How non-traditional investors fuel up-and-coming biotechs when VC funding dries up
Pharma Voice
Tue, 03/18/25 - 11:23 am
R&D
biotech
funding
Bluebird’s go-private deal highlights fraught life preserver for struggling biotechs
BioSpace
Wed, 03/12/25 - 11:19 am
Bluebird Bio
funding
biotech
restructuring
[podcast]What to expect from the biotech IPO market in 2025
Fierce Biotech
Fri, 01/31/25 - 11:18 am
biotech
IPOs
JPMHC 2025
Metsera, Maze secure combined $415 million in IPOs
BioPharma Dive
Fri, 01/31/25 - 11:05 am
Metsera
Maze Therapeutics
IPOs
biotech
Executive hiring changes reflect a broader biotech comeback
Pharma Voice
Thu, 01/30/25 - 10:49 am
biotech
executives
The biopharma industry outlook on 2025: Uncertainty and change
BioPharma Dive
Sun, 01/26/25 - 04:16 pm
biotech
JPMHC 2025
China
regulatory
Donald Trump
‘A really rational IPO environment’: What does it takes for a biotech to go public now?
Fierce Biotech
Fri, 01/24/25 - 11:44 am
biotech
IPOs
Septerna
Sofinnova
Rapport Therapeutics
Biopharma’s AI rally: Readiness not hype in 2025
Pharmaphorum
Thu, 01/16/25 - 11:01 am
biotech
artificial intelligence
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A

Pages